Interestingly, we noted that PIK3CA mutants cooccurred with other genetic alterations that promote enhanced PI3K signaling [18, 19]; for example, mutations in PIK3CA were found concomitantly with mutations in EGFR, KRAS, or ALK in the same tumors of lung cancer patients [5]. This evidence concerns the gene PIK3CA and lung carcinoma.